thiophenes has been researched along with Bladder Cancer in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brandão, GC; Ferreira, GM; Lima, APB; Pereira, GR; Silva, GND | 1 |
| Al-Obaidy, KI; Cheng, L | 1 |
| Hubert, P; Loriot, Y; Selmani, Z; Thiery-Vuillemin, A | 1 |
| Celetti, A; Cerrato, A; Criscuolo, D; Giannella, R; Ilardi, G; Insabato, L; Merolla, F; Morra, F; Staibano, S; Visconti, R | 1 |
| Cogoi, S; Membrino, A; Shchekotikhin, AE; Sinkevich, YB; Xodo, LE | 1 |
| Du, B; Li, R; Li, X; Liu, Y; Wei, Q; Wu, D; Zhang, S; Zhang, Y | 1 |
| Kwiatkowski, DJ; Liu, Y | 1 |
| Cogoi, S; Shchekotikhin, AE; Xodo, LE; Zorzet, S | 1 |
| Cinatl, J; Hoffmann, MJ; Isono, M; Michaelis, M; Niegisch, G; Pinkerneil, M; Sato, A; Schulz, WA | 1 |
| Bolognese, A; Caputo, M; Di Cello, P; Izzo, L; Izzo, P; Meloni, P; Pietrasanta, D | 1 |
| Babu, J; Munday, CM; Munday, R; Paonessa, JD; Wilkins, AL; Zhang, Y | 1 |
| Boddy, AV; Heer, R; Karran, P; Newell, DR; O'Toole, K; Pridgeon, SW; Robinson, M; Taylor, GA; Xu, YZ | 1 |
| Dai, G; Wang, X | 1 |
| Akaza, H; Hattori, K; Iida, K; Itoh, K; Kawai, K; Kumagai, Y; Oyasu, R; Shimazui, T; Yamamoto, M | 1 |
| Erlichman, C; Hedley, DW; Mitrovski, B; Pressacco, J | 1 |
| Erlichman, C; Mandelbaum, S; Mitrovski, B; Pressacco, J | 1 |
| Chen, LB; Garlid, KD; Hu, J; Song, K; Sun, X; Wong, JR | 1 |
| Firby, PS; Hedley, DW; Moore, MJ; Rauchwerger, DR | 1 |
| Biondo, F; Caramia, G; Gebbia, N; Pavone-Macaluso, M; Rausa, L; Rizzo, FP | 1 |
| Carter, SK; Goldsmith, MA | 1 |
3 review(s) available for thiophenes and Bladder Cancer
| Article | Year |
|---|---|
Fibroblast growth factor receptor (
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Exons; Gene Amplification; Gene Fusion; Genetic Predisposition to Disease; Humans; Molecular Targeted Therapy; Mutation, Missense; Phenotype; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 3; Thiophenes; Urinary Bladder Neoplasms; Urothelium | 2021 |
[Development of bladder cancer chemoprevention].
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Papillary; Humans; Neoplasm Recurrence, Local; Piroxicam; Pyrazines; Retinoids; Thiones; Thiophenes; Urinary Bladder Neoplasms | 2003 |
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms | 1973 |
2 trial(s) available for thiophenes and Bladder Cancer
| Article | Year |
|---|---|
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Anemia, Aplastic; Antineoplastic Agents; Blood Platelet Disorders; Child; Clinical Trials as Topic; Female; Gastrointestinal Diseases; Glycosides; Hematopoiesis; Hodgkin Disease; Humans; Lactones; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Remission, Spontaneous; Thiophenes; Urinary Bladder Neoplasms | 1972 |
4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
Topics: Alopecia; Animals; Brain Neoplasms; Clinical Trials as Topic; DNA; Glycosides; Hodgkin Disease; Humans; Hypotension; Leukopenia; Mitosis; Neoplasms, Experimental; Podophyllotoxin; Solubility; Structure-Activity Relationship; Thiophenes; Urinary Bladder Neoplasms | 1973 |
17 other study(ies) available for thiophenes and Bladder Cancer
| Article | Year |
|---|---|
Synthesis, characterization and antiproliferative effects of naphtho [2,3-
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Naphthoquinones; Reactive Oxygen Species; Thiophenes; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |
FGFR alterations in urothelial carcinoma: Picking the right target.
Topics: Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Gene Fusion; Humans; Molecular Targeted Therapy; Morpholines; Mutation; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Thiophenes; Urinary Bladder Neoplasms | 2021 |
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
Topics: Antineoplastic Agents; Azetidines; Biomarkers, Tumor; Cell Line, Tumor; Cytoskeletal Proteins; DNA Damage; Genes, Tumor Suppressor; Humans; Nitro Compounds; Poly(ADP-ribose) Polymerase Inhibitors; Thiophenes; Ubiquitin-Specific Peptidase 7; Urinary Bladder Neoplasms | 2019 |
Guanidino anthrathiophenediones as G-quadruplex binders: uptake, intracellular localization, and anti-Harvey-Ras gene activity in bladder cancer cells.
Topics: Animals; Cell Division; Cell Line, Tumor; Endocytosis; Flow Cytometry; G-Quadruplexes; Genes, ras; Humans; Mice; NIH 3T3 Cells; Thiophenes; Urinary Bladder Neoplasms | 2013 |
A novel multi-amplification photoelectrochemical immunoassay based on copper(II) enhanced polythiophene sensitized graphitic carbon nitride nanosheet.
Topics: Biomarkers, Tumor; Biosensing Techniques; Copper; Electrochemical Techniques; Graphite; Humans; Immunoassay; Limit of Detection; Nanostructures; Nitriles; Nuclear Proteins; Polymers; Thiophenes; Titanium; Urinary Bladder Neoplasms | 2014 |
Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Mice; Mutation; Protein Kinases; Pyrazoles; Thiophenes; Tumor Suppressor Protein p53; Urea; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells.
Topics: Acetamides; Alleles; Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Design; G-Quadruplexes; G2 Phase Cell Cycle Checkpoints; Genes, ras; Humans; Mice; Substrate Specificity; Survival Analysis; Thiophenes; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Checkpoint Kinase 2; Deoxycytidine; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; RNA, Small Interfering; Thiophenes; Urea; Urinary Bladder Neoplasms | 2017 |
A case of relapsing secondary bladder adenocarcinoma after right colonic cancer.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cecal Neoplasms; Cetuximab; Chemotherapy, Adjuvant; Colectomy; Female; Fluorouracil; Humans; Immunohistochemistry; Irinotecan; Leucovorin; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Organoplatinum Compounds; Quinazolines; Retroperitoneal Neoplasms; Sacrum; Thiophenes; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2008 |
Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Enzyme Induction; Female; Gene Knockdown Techniques; Glutathione Transferase; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Organ Specificity; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiones; Thiophenes; Urinary Bladder; Urinary Bladder Neoplasms | 2010 |
Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; DNA Damage; Female; Humans; Quinazolines; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344; Thiophenes; Thymidine; Ultraviolet Therapy; Urinary Bladder Neoplasms | 2011 |
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; DNA-Binding Proteins; Enzyme Induction; Female; Gene Expression; Genetic Predisposition to Disease; Glucuronides; Glucuronosyltransferase; Inactivation, Metabolic; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Microsomes, Liver; NF-E2-Related Factor 2; Pyrazines; Thiones; Thiophenes; Trans-Activators; Urinary Bladder; Urinary Bladder Neoplasms | 2004 |
Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression.
Topics: Carrier Proteins; Humans; Indoles; Membrane Proteins; Nucleoside Transport Proteins; Quinazolines; Thiophenes; Thymidine Kinase; Thymidylate Synthase; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells.
Topics: Cell Survival; Deoxyuracil Nucleotides; Deoxyuridine; Folic Acid; Folic Acid Antagonists; Glutamates; Humans; In Vitro Techniques; Indoles; Isoindoles; Quinazolines; Structure-Activity Relationship; Thiophenes; Thymidylate Synthase; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
Topics: Adenocarcinoma; Adenosine Triphosphate; Aniline Compounds; Animals; Antineoplastic Agents; Chlorocebus aethiops; Colonic Neoplasms; Disease Models, Animal; Epithelium; Female; Humans; Hydrolysis; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitochondria, Liver; Models, Biological; Neoplasm Transplantation; Ovarian Neoplasms; Oxygen Consumption; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Survival; Deoxycytidine; Equilibrative Nucleoside Transport Proteins; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Fluorouracil; Gemcitabine; Humans; Inhibitory Concentration 50; Pancreatic Neoplasms; Purine Nucleosides; Quinazolines; Thiophenes; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2000 |
Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Nucleus; Cricetinae; Cytotoxicity Tests, Immunologic; Daunorubicin; Demecolcine; DNA, Neoplasm; Doxorubicin; Drug Resistance; Fluorescence; Glycosides; Humans; Melphalan; Microscopy, Fluorescence; Neoplasm Transplantation; Oxidoreductases; Podophyllotoxin; Protein Biosynthesis; Thiophenes; Thiotepa; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1973 |